Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further t

CORT discovers, develops, and sells medications to treat severe metabolic, oncologic, and psychiatri

FAS Wealth Partners Inc. increased its stake in Corcept Therapeutics Incorporated (NASDAQ: CORT) by

Avidity Partners Management LP lifted its stake in Corcept Therapeutics Incorporated (NASDAQ: CORT)

Corcept Therapeutics remains a 'Hold' as LIFYORLI's strong launch and clinical demand are already re

Microsoft's 43% cloud growth revived the AI trade and lifted chipmakers, but Meta's guidance

Corcept tops Q2 earnings estimates as Korlym growth and a strong Lifyorli launch lift revenues, prom

Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 123.7% to $4.23 during Thursday's regular

Dow Jones index gained 300 points, Lam Research Corp rose 20.1% after reporting strong financial res

Gainers Nuwellis (NASDAQ:NUWE) stock rose 119.0% to $4.14 during Thursday's pre-market session.

Microsoft (NASDAQ: MSFT) reported strong Q4 results, beating revenue and earnings estimates. Shares

Corcept Therapeutics Incorporated (CORT) Q2 2026 Earnings Call Transcript

Corcept Therapeutics (CORT) came out with quarterly earnings of $0.36 per share, beating the Zacks C

Corcept Therapeutics NASDAQ: CORT reported second-quarter 2026 revenue of $256.1 million, up 32% fro

Gainers Nuwellis (NASDAQ:NUWE) stock rose 40.2% to $2.65 during Wednesday's after-market sessio

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercia

Top Wall Street analysts changed outlook on several top stocks. See all changes on analyst ratings p

Here is how Corcept Therapeutics (CORT) and Quest Diagnostics (DGX) have performed compared to their

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT) today announ

President Donald Trump has announced that all generic drugs imported into the United States would co

FBT delivered 52.4% returns over one year but with deeper drawdowns, while XLV's diversified approac

The transaction involved 40,000 shares with an estimated value of $3.5 million on the July 15, 2026

The transaction involved the sale of 10,000 shares at $88.30 per share, resulting in a total value o

The transaction realized $1.9 million in gross proceeds on July 7, 2026, at a weighted average price

Corcept Therapeutics maintains a Buy rating, supported by robust revenue growth, pipeline progress,

Crinetics Pharmaceuticals (NASDAQ:CRNX | CRNX Price Prediction) shares have climbed 99% just this we

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

NEW YORK, June 25, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is inves

Top Wall Street analysts changed outlook on top names. See all analyst rating changes, including upg

Needham analyst Rick Patel maintained a Buy rating. Steven Madden shares closed at $47.27 on Friday.

Top analysts change outlook for top names. Citigroup, Tigress Fin, Piper Sandler, Morgan Stanley, HC

U.S. stocks rose, with the Dow Jones gaining 350 points on Wednesday. AAR Corp (NYSE: AIR) saw a 10.

US stocks rise with the Dow gaining over 300 points. Chewy shares jump 14%. Sarepta Therapeutics sur

Stocks slipped Thursday as Trump comments on Iran lifted oil prices, boosting energy shares while fi

Precious metals continued to dominate Wall Street headlines on Friday as silver surged through the $

U.S. stocks surged midday Thursday as strong GDP data pushed the Russell 2000 to record highs and in

Benzinga examined the prospects for many investors' favorite stocks over the last week — here&#3

Wall Street lacked clear direction on Tuesday, as mixed labor market data failed to ignite a fresh w